남성 불임 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00007061
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 280
Buy Now

[연구보고서]남성 난임 시장은 2019년 38억 8,382만 달러에서 2027년 62억 1,396만 달러에 달할 것으로 예상된다. 2020년부터 2027년까지 CAGR 6.2%로 성장할 것으로 추정됩니다.



전 세계적으로 남성 불임 증가 및 기술 발전과 같은 요인이 시장 성장을 주도합니다. 그러나 높은 절차 비용은 남성 불임 시장의 성장을 방해합니다.



남성 불임에 대한 수익성 있는 지역 시장



시장 통찰력



전 세계 남성 불임 증가



h3>

남성의 불임은 지역마다 유병률이 다른 세계적인 문제입니다. 남성 불임의 주요 원인은 정액의 부족과 정액의 질 저하입니다. 미국 국립보건원(NIH)에 따르면 2016년 전 세계적으로 약 15%의 커플, 즉 약 4,850만 커플이 불임에 영향을 미쳤습니다. 또한 2016년 Journal of Reproductive Biology and Endocrinology에 발표된 연구 조사에 따르면 불임은 남성의 비율은 아프리카와 동/중부 유럽에서 가장 높은 것으로 나타났습니다. 세계보건기구(WHO)에 따르면 불임 부부의 약 20%는 남성 파트너에게 문제가 있는 반면, 부부의 30%는 두 파트너 모두에게 문제가 있습니다. 따라서 남성은 전 세계적으로 불임 사례의 ~50%에 기여합니다. 또한 호주 정부 보건부에서 자금을 지원하는 건강한 남성 남성학 호주(Healthy Male Andrology Australia)에 따르면 남성 20명 중 1명은 적은 수의 정자를 생산하여 불임으로 이어지며 남성 100명 중 1명은 정자가 전혀 없습니다.



남성의 불임의 원인이 되는 몇 가지 일반적인 요인에는 뇌하수체의 낮은 호르몬 생산 수준, 정액이 질관으로 들어가는 데 영향을 미치는 성적 문제, 정자 항체의 존재 등이 있습니다. Varicocele, 즉 고환에 확장된 정맥이 존재하는 것은 남성의 낮은 정자 수의 가장 흔한 원인입니다. 미국 보건복지부(US Department of Health and Human Services)에 따르면 정계정맥류는 불임 문제를 겪고 있는 남성의 약 40%에 존재합니다.



따라서 남성 불임의 엄청난 유병률은 남성 불임 치료 및 서비스에 대한 더 큰 수요를 창출하고 있습니다. .



테스트 기반 인사이트



테스트 기반의 글로벌 남성 불임 시장은 DNA 단편화 기술, 산화 스트레스 분석, 컴퓨터 보조 정액 분석, 현미경 검사, 정자 응집, 정자 침투 분석 및 기타. DNA 단편화 기술 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 반면 컴퓨터 보조 정액 분석 부문은 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.



글로벌 남성 불임 시장, 테스트 기준 - 2019년 및 2027년



치료 유형- 기반 통찰력



치료 유형에 따라 남성 불임 시장은 보조 생식 기술 및 정맥류 수술과 약물로 분류됩니다. 보조 생식 기술 및 정맥류 수술 부문은 2019년에 더 큰 시장 점유율을 차지했으며 예측 기간 동안 시장에서 더 높은 CAGR을 기록할 것으로 예상됩니다.



유통 채널 기반 통찰력



< p>남성 난임 시장은 유통 채널을 기준으로 병원 약국, 약국 및 약국, 온라인 약국으로 구분됩니다. 2019년에는 병원 약국 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한 동일한 세그먼트에 대한 시장은 2020-2027년 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.



최종 사용자 기반 통찰력



최종 사용자를 기반으로 한 남성 불임 시장은 불임 센터, 병원 및 진료소, 연구 기관 및 기타 최종 사용자로 분류됩니다. 2019년에는 불임 센터 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한 동일한 세그먼트가 2020년부터 2027년까지 시장에서 가장 높은 CAGR 6.8%를 기록할 것으로 예상됩니다.



전략적 통찰력



Vitrolife 및 Halotech DNA와 같은 회사는 여러 가지 무기물을 채택했습니다. 남성 불임 시장에서 그들의 수익과 위치를 강화하기 위한 유기농 전략. 주요 업체의 관련 성과로 인해 시장에서 더 나은 서비스와 제품을 사용할 수 있게 되었습니다.



남성 불임 시장 - 테스트별




  • DNA 단편화 기술

  • 산화 스트레스 분석

  • 현미경 검사

  • 정자 응집

  • 컴퓨터 보조 정액 분석

  • 정자 침투 분석

  • < li>기타

남성 불임 시장 - 치료 유형별




  • 보조 생식 기술

    • 체외 수정(IVF)
    • 세포질 내 정자 주입(ICSI)



  • 정맥류 수술

  • 의약품


남성 불임 시장 - 유통 채널별




  • 병원 약국

  • 약국 및 약국

  • 온라인 약국


남성 불임 시장 - 최종 사용자별




  • 병원 및 클리닉

  • 불임 센터

  • 연구 기관

  • 기타 최종 사용자

  • 남성 불임 시장 - 지역별




    • 북미

      • 미국

      • 캐나다

      • 멕시코



    • 유럽

      • 독일

      • 영국

      • 프랑스

      • 이탈리아

      • 스페인

      • 스웨덴

      • 덴마크

      • 폴란드

      • 터키

      • 네덜란드

      • 벨기에

      • 핀란드

      • 스위스

      • 아일랜드

      • 노르웨이

      • 기타 유럽



    • 아시아 태평양(APAC)

      • 일본

      • 중국

      • 인도

      • 대한민국

      • 호주

      • 태국

      • 싱가포르

      • 뉴질랜드

      • 베트남

      • 아시아 태평양 나머지 지역



    • 중동 및 아프리카(MEA)

      • UAE

      • 사우디아라비아

      • 남아프리카공화국

      • 이집트

      • 이스라엘

      • 기타 중동 및 아프리카



    • 중남미(SCAM)

      • 브라질

      • 아르헨티나

      • 나머지 중남미




    회사 프로필




    • MERCK KGaA

    • Sanofi

    • Bayer AG

    • Endo Pharmaceuticals Inc.

    • SCSA Diagnostics, Inc.

    • < li>남성학 솔루션
    • Halotech DNA

    • INTAS PHARMACEUTICALS LTD.

    • Cadila Pharmaceuticals Ltd.

    • Vitrolife

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is male infertility?

Male infertility is due to low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems, lifestyle choices such as Smoking, drinking alcohol, and taking certain medications can lower sperm numbers. Other causes of low sperm numbers include long-term sickness (such as kidney failure), childhood infections (such as mumps), and chromosome or hormone problems (such as low testosterone). In over a third of infertility cases, the problem is with the man. This is most often due to problems with the sperm production or with sperm delivery.

What are the driving factors for the male infertility market across the globe?

The male infertility market is estimated to grow owing to key driving factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. However, high cost of the procedures is likely to hamper the growth of the market during the forecast period.

What is the regional market scenario of male infertility?

Global male infertility market is segmented by region into North America, Europe, Asia-Pacific, Middle East & Africa and South & Central America. In North America, the U.S. holds a significant share of the male infertility market. Innovations in the product line primarily drive the growth of the market in the country. The country focuses on changing the overall landscape and the best in the class healthcare infrastructure, advanced facilities, and awareness and openness amongst citizens towards the disease.The increasing infertility rate in the country is the primary factor driving growth during the study period. For instance, Infertility is a common problem, with more than 5 million couples in the United States dealing with these problems. It affects one in every six couples who are trying to conceive. In at least half of all cases of Infertility, a malefactor is a primary or contributing cause. This means that about 10% of all men in the United States attempting to conceive suffer from Infertility.

The List of Companies - Male Infertility Market

  1. MERCK KGaA
  2. Sanofi
  3. Bayer AG
  4. Endo Pharmaceuticals Inc.
  5. SCSA Diagnostics, Inc.
  6. Andrology Solutions
  7. Halotech DNA
  8. INTAS PHARMACEUTICALS LTD.
  9. Cadila Pharmaceuticals Ltd.
  10. Vitrolife.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports